Peripheral WebinarsEditor's PickEditors Pick HomepageEditors Pick PeripheralLatest news PeripheralPeripheralLearning Areas COVID-19: The role of vascular surgeons—A New York centre perspective
LINC 2020Editor's PickInterviewsEditors Pick HomepageEditors Pick PeripheralPeripheral InterviewsLatest news PeripheralPeripheralLearning AreasEventsVideo Types Real-world data with long-term follow-up confirm no increased mortality signal with paclitaxel-based devices
VIVA 2019Editor's PickEditors Pick HomepageInterviewsEditors Pick PeripheralPeripheral InterviewsLatest news PeripheralPeripheralLearning AreasEventsVideo Types Tack Endovascular System® reveals “impressive” six-month results below the knee
PresentationsPeripheralPeripheral PresentationsLearning AreasCX 2019Events CX 2019: Statistical review of methodology and legitimacy of results
PresentationsPeripheral PresentationsPeripheralCX 2019Learning AreasEvents CX 2019: Patient-level data from the IN.PACT Clinical Programme: Is paclitaxel safe for treatment of PAD?
PresentationsPeripheralPeripheral PresentationsLearning AreasCX 2019Events CX 2019: What does Big Data tell us about survival following PAD revascularisation using drug technologies?
PresentationsPeripheral PresentationsPeripheralLearning AreasCX 2019Events CX 2019: Two-year outcomes from four pooled multicentre RCTs: Safety after treatment with PTX-coated devices
PresentationsPeripheralPeripheral PresentationsCX 2019Learning AreasEvents CX 2019: SWEDEPAD trials – withdrawal of paclitaxel use
Editor's PickRoundtablesEditors Pick HomepagePeripheral RoundtablesLatest news PeripheralPeripheralEditors Pick PeripheralCX 2019Learning AreasEvents Number of vascular surgeons being trained is “woefully inadequate”
